440PA multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting (ESPRESSO-02/HGCSG1602). (25th November 2018) - Nakamura, M; Muranaka, T; Yagisawa, M; Kawamoto, Y; Yuki, S; Ishiguro, A; Dazai, M; Sogabe, S; Harada, K; Kobayashi, Y; Miyagishima, T; Okamura, N; et al.